메뉴 건너뛰기




Volumn 75, Issue 2, 2009, Pages 442-448

Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer

Author keywords

Antineoplastic agents; Bladder neoplasms; Fluorouracil; Paclitaxel; Transitional cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; FLUOROURACIL; PACLITAXEL; TRANSITIONAL CELL CARCINOMA;

EID: 68049125166     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.030     Document Type: Article
Times cited : (28)

References (24)
  • 1
    • 0035254218 scopus 로고    scopus 로고
    • Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
    • Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
    • (2001) J Clin Oncol , vol.19 , pp. 666-675
    • Stein, J.P.1    Lieskovsky, G.2    Cote, R.3
  • 2
    • 0035097992 scopus 로고    scopus 로고
    • Cystectomy for bladder cancer: A contemporary series
    • Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: A contemporary series. J Urol 165 (2001) 1111-1116
    • (2001) J Urol , vol.165 , pp. 1111-1116
    • Dalbagni, G.1    Genega, E.2    Hashibe, M.3
  • 3
    • 0037441652 scopus 로고    scopus 로고
    • Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy
    • Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
    • (2003) J Clin Oncol , vol.21 , pp. 690-696
    • Madersbacher, S.1    Hochreiter, W.2    Burkhard, F.3
  • 4
    • 33745231164 scopus 로고    scopus 로고
    • Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era
    • Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era. J Urol 176 (2006) 486-492
    • (2006) J Urol , vol.176 , pp. 486-492
    • Hautmann, R.E.1    Gschwend, J.E.2    de Petriconi, R.C.3
  • 5
    • 85014013850 scopus 로고    scopus 로고
    • Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
    • International Collaboration of Trialists
    • International Collaboration of Trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. Lancet 354 (1999) 533-540
    • (1999) Lancet , vol.354 , pp. 533-540
  • 6
    • 0041429507 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
    • Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
    • (2003) N Engl J Med , vol.349 , pp. 859-866
    • Grossman, H.B.1    Natale, R.B.2    Tangen, C.M.3
  • 7
    • 0000278788 scopus 로고    scopus 로고
    • Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
    • UKCCCR Anal Cancer Trial Working Party
    • UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348 (1996) 1049-1054
    • (1996) Lancet , vol.348 , pp. 1049-1054
  • 8
    • 0025807080 scopus 로고
    • Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
    • Department of Veterans Affairs Laryngeal Cancer Study Group
    • Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
    • (1991) N Engl J Med , vol.324 , pp. 1685-1690
  • 9
    • 0029851252 scopus 로고    scopus 로고
    • Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group
    • Coppin C.M., Gospodarowicz M.K., James K., et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14 (1996) 2901-2907
    • (1996) J Clin Oncol , vol.14 , pp. 2901-2907
    • Coppin, C.M.1    Gospodarowicz, M.K.2    James, K.3
  • 10
    • 0031763392 scopus 로고    scopus 로고
    • Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03
    • Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16 (1998) 3576-3583
    • (1998) J Clin Oncol , vol.16 , pp. 3576-3583
    • Shipley, W.U.1    Winter, K.A.2    Kaufman, D.S.3
  • 11
    • 33644838678 scopus 로고    scopus 로고
    • Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
    • Lin C.C., Hsu C.H., Huang C.Y., et al. Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity. Cancer 106 (2006) 1269-1275
    • (2006) Cancer , vol.106 , pp. 1269-1275
    • Lin, C.C.1    Hsu, C.H.2    Huang, C.Y.3
  • 12
    • 33845342862 scopus 로고    scopus 로고
    • Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma
    • Lin C.C., Hsu C.H., Huang C.Y., et al. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma. J Urol 177 (2007) 84-89
    • (2007) J Urol , vol.177 , pp. 84-89
    • Lin, C.C.1    Hsu, C.H.2    Huang, C.Y.3
  • 13
    • 33947254983 scopus 로고    scopus 로고
    • Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens
    • Lin C.C., Hsu C.H., Huang C.Y., et al. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens. Urology 69 (2007) 479-484
    • (2007) Urology , vol.69 , pp. 479-484
    • Lin, C.C.1    Hsu, C.H.2    Huang, C.Y.3
  • 14
    • 0028969271 scopus 로고
    • Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
    • Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 15
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
    • (1989) Control Clin Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 16
    • 1542299243 scopus 로고    scopus 로고
    • Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
    • Michaelson M.D., Shipley W.U., Heney N.M., et al. Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder. Br J Cancer 90 (2004) 578-581
    • (2004) Br J Cancer , vol.90 , pp. 578-581
    • Michaelson, M.D.1    Shipley, W.U.2    Heney, N.M.3
  • 17
    • 0141615695 scopus 로고    scopus 로고
    • RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy
    • Hagan M.P., Winter K.A., Kaufman D.S., et al. RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 665-672
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 665-672
    • Hagan, M.P.1    Winter, K.A.2    Kaufman, D.S.3
  • 18
    • 0027452436 scopus 로고
    • Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study
    • Housset M., Maulard C., Chretien Y., et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J Clin Oncol 11 (1993) 2150-2157
    • (1993) J Clin Oncol , vol.11 , pp. 2150-2157
    • Housset, M.1    Maulard, C.2    Chretien, Y.3
  • 19
    • 0036290017 scopus 로고    scopus 로고
    • Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer
    • Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67
    • (2002) Urology , vol.60 , pp. 62-67
    • Shipley, W.U.1    Kaufman, D.S.2    Zehr, E.3
  • 20
    • 0037099683 scopus 로고    scopus 로고
    • Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results
    • Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20 (2002) 3061-3071
    • (2002) J Clin Oncol , vol.20 , pp. 3061-3071
    • Rodel, C.1    Grabenbauer, G.G.2    Kuhn, R.3
  • 21
    • 34447096867 scopus 로고    scopus 로고
    • Long-term outcome of radiation-based conservation therapy for invasive bladder cancer
    • Chung P.W., Bristow R.G., Milosevic M.F., et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol 25 (2007) 303-309
    • (2007) Urol Oncol , vol.25 , pp. 303-309
    • Chung, P.W.1    Bristow, R.G.2    Milosevic, M.F.3
  • 22
    • 0031868628 scopus 로고    scopus 로고
    • Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients
    • Wijkstrom H., Norming U., Lagerkvist M., et al. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients. Br J Urol 81 (1998) 686-691
    • (1998) Br J Urol , vol.81 , pp. 686-691
    • Wijkstrom, H.1    Norming, U.2    Lagerkvist, M.3
  • 23
    • 0343775631 scopus 로고    scopus 로고
    • Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation
    • Rodel C., Grabenbauer G.G., Rodel F., et al. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys 46 (2000) 1213-1221
    • (2000) Int J Radiat Oncol Biol Phys , vol.46 , pp. 1213-1221
    • Rodel, C.1    Grabenbauer, G.G.2    Rodel, F.3
  • 24
    • 21044446131 scopus 로고    scopus 로고
    • Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group
    • Chakravarti A., Winter K., Wu C.L., et al. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62 (2005) 309-317
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , pp. 309-317
    • Chakravarti, A.1    Winter, K.2    Wu, C.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.